The hepatic levels of the Na+/BA-cotransporter Slc10a1 were significantly higher in NOD1 KO vs. WT mice in CHD regimen, suggesting that the enterohepatic circulation of BA into hepatocytes was reduced upon HFD treatment. This evidence concerns the gene NOD1 and coronary artery disorder.